Cancers of unknown primary: survival by histologic type, demographic features, and treatment in the US Military Health System

被引：0
|
作者：
Bytnar, Julie A.
Lin, Jie
Moncur, Joel T.
Shriver, Craig D.
Zhu, Kangmin
机构：
来源：
CANCER RESEARCH | 2023年 / 83卷 / 07期
关键词：
D O I：
10.1158/1538-7445.AM2023-4209
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
4209
引用
收藏
页数：2
相关论文
共 47 条
  • [41] Comparative study of survival among small cell lung cancer patients in the US military health system and those in the surveillance, epidemiology, and end results (SEER) program
    Lin, Jie
    Kamamia, Christine
    Brown, Derek W.
    Shao, Stephanie
    McGlynn, Katherine A.
    Nations, Joel A.
    Carter, Corey A.
    Shriver, Craig D.
    Zhu, Kangmin
    ANNALS OF EPIDEMIOLOGY, 2021, 64 : 132 - 139
  • [42] Comment on Dorobisz et al. Assessment of Prognostic Factors, Clinical Features Including the Microbiome, and Treatment Outcomes in Patients with Cancer of Unknown Primary Site. Cancers 2024, 16, 3416
    Itagaki, Tatsuki
    Kasai, Machiko
    Sakata, Ken-ichiro
    Hasebe, Akira
    CANCERS, 2024, 16 (23)
  • [43] Adherence to antidiabetic treatment in primary health care in individuals with type 2 diabetes. A survey including socio-demographic, patient related and clinical factors
    Silva-Tinoco, Ruben
    Cuatecontzi-Xochitiotzi, Teresa
    Bernal-Ceballos, Fernanda
    De laTorre-Saldan, Viridiana
    Galindez-Fuentes, Ana
    Castillo-Martinez, Lilia
    PRIMARY CARE DIABETES, 2022, 16 (06) : 780 - 785
  • [44] MEDICAL SERVICE COST ASSOCIATED WITH PIOGLITAZONE AND SULFONYLUREA TREATMENT AMONG TYPE 2 DIABETIC PATIENTS ENROLLED IN A US INTEGRATED HEALTH-CARE SYSTEM
    Sun, S. X.
    Ma, L.
    Bron, M.
    Lamothe, K.
    Boulanger, L.
    VALUE IN HEALTH, 2010, 13 (07) : A526 - A526
  • [45] Reply to Itagaki et al. Comment on "Dorobisz et al. Assessment of Prognostic Factors, Clinical Features Including the Microbiome, and Treatment Outcomes in Patients with Cancer of Unknown Primary Site. Cancers 2024, 16, 3416"
    Dorobisz, Karolina
    Dorobisz, Tadeusz
    Pazdro-Zastawny, Katarzyna
    CANCERS, 2024, 16 (23)
  • [46] Consolidation Improves Survival in Primary Central Nervous System Lymphoma without Preference for Type of High-Dose Methotrexate-Based Induction Treatment Regimen
    De Groot, Fleur A.
    Doorduijn, Jeanette K.
    Brink, Mirian
    De Groen, Ruben A. L.
    De Haan, Lorraine M.
    Noordenbos, Troy
    Sijs-Szabo, Aniko
    Lam, King Hong
    Diepstra, Arjan
    te Boome, Liane
    Terpstra, Valeska
    Bohmer, Lara H.
    Zijlstra, Josee M.
    Koens, Lianne
    Durian, Marc
    Oudshoorn, Mirjam A.
    Veelken, Hendrik
    Van der Poel, Marjolein W. M.
    Hamid, Myrurgia Abdul
    Stevens, Wendy B. C.
    van Rooij, J. L. M.
    Oostvogels, Rimke
    Neelis, Karen J.
    van den Brand, Michiel
    Woei-A-Jin, F. J. Sherida H.
    Tousseyn, Thomas
    Dierickx, Daan
    Jansen, Patty M.
    Kersten, Marie Jose
    Bromberg, Jacoline
    Nijland, Marcel
    Vermaat, Joost S. P.
    BLOOD, 2022, 140
  • [47] Underserved Pacific Islanders With Locally Advanced Cervical Cancer Receive Higher Rates of Standard-of-Care Radiation Treatment Through the Pacific Island Health Care Project and Military Health System Compared to the Average US Population
    Sitler, Collin
    Bunch, Kristen P.
    Padro, David
    Miller, Caela R.
    MILITARY MEDICINE, 2023, 188 (3-4) : E792 - E796
12345